Trendzon Holdings Group Limited announced that on 12 September 2023, the Company entered into a cooperation framework agreement with Zhongfa Fudekang Biotechnology Co., Limited. The parties are committed to establishing a comprehensive and long-term partnership. The parties will give full play to their respective advantages in resources, capital, market development and industrial chain resources.

The scope of cooperation between the two parties focuses on the Group's business layout and strategic plan in China's domestic market. The parties initially plan to jointly build biopharmaceutical and new materials industrial parks in Taiyuan of Shanxi Province, Shanghai, Jiangsu Province, Jiangxi Province, the Guangdong-Hong Kong-Macao Greater Bay Area, and nationwide covering an area of 1,000 acres. According to the information currently available to the Group, Zhongfa was established in November 2018 and mainly focuses on the research and production of modified starch plant capsules.

To the best of the Directors' knowledge, information and belief having made reasonable enquiries, Zhongfa and its ultimate beneficial owners are independent third parties of the Group and they are not connected persons of the Group (as defined in the Rules Governing the Listing of Securities on of The Stock Exchange of Hong Kong Limited) (the Listing Rules). The Board believes that the Group will leverage on its advantages in industrial chains, and through cooperation with the Partner, it will provide support for cooperation projects between the parties in terms of industrial chain coverage, and foreign capital injection. The parties will leverage on their respective advantages in project development, investment, research, and operation stages, and realize project cooperation by means of mutually beneficial sharing of resources.

Both parties will jointly build biopharm pharmaceutical and new materials industrial parks, and also plan to build an industrial base covering an area of 1,000 acres. The terms of the Framework Agreement were determined after arm's length negotiations between the parties, are fair and reasonable, and are in the interests of the Company and its shareholders as a whole.